Cargando…
Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89]
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680478/ https://www.ncbi.nlm.nih.gov/pubmed/28279639 http://dx.doi.org/10.1016/j.ebiom.2017.02.027 |
_version_ | 1783277768525479936 |
---|---|
author | Huang, Chung-Feng Huang, Ching-I Yeh, Ming-Lun Wang, Shu-Chi Chen, Kuan-Yu Ko, Yu-Min Lin, Ching-Chih Tsai, Yi-Shan Tsai, Pei-Chien Lin, Zu-Yau Chen, Shinn-Cherng Dai, Chia-Yen Huang, Jee-Fu Chuang, Wan-Long Yu, Ming-Lung |
author_facet | Huang, Chung-Feng Huang, Ching-I Yeh, Ming-Lun Wang, Shu-Chi Chen, Kuan-Yu Ko, Yu-Min Lin, Ching-Chih Tsai, Yi-Shan Tsai, Pei-Chien Lin, Zu-Yau Chen, Shinn-Cherng Dai, Chia-Yen Huang, Jee-Fu Chuang, Wan-Long Yu, Ming-Lung |
author_sort | Huang, Chung-Feng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5680478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-56804782017-11-20 Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] Huang, Chung-Feng Huang, Ching-I Yeh, Ming-Lun Wang, Shu-Chi Chen, Kuan-Yu Ko, Yu-Min Lin, Ching-Chih Tsai, Yi-Shan Tsai, Pei-Chien Lin, Zu-Yau Chen, Shinn-Cherng Dai, Chia-Yen Huang, Jee-Fu Chuang, Wan-Long Yu, Ming-Lung EBioMedicine Corrigendum Elsevier 2017-03-01 /pmc/articles/PMC5680478/ /pubmed/28279639 http://dx.doi.org/10.1016/j.ebiom.2017.02.027 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Corrigendum Huang, Chung-Feng Huang, Ching-I Yeh, Ming-Lun Wang, Shu-Chi Chen, Kuan-Yu Ko, Yu-Min Lin, Ching-Chih Tsai, Yi-Shan Tsai, Pei-Chien Lin, Zu-Yau Chen, Shinn-Cherng Dai, Chia-Yen Huang, Jee-Fu Chuang, Wan-Long Yu, Ming-Lung Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title | Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title_full | Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title_fullStr | Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title_full_unstemmed | Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title_short | Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment” [EBioMedicine 15 (2017) 81–89] |
title_sort | corrigendum to “genetics variants and serum levels of mhc class i chain-related a in predicting hepatocellular carcinoma development in chronic hepatitis c patients post antiviral treatment” [ebiomedicine 15 (2017) 81–89] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680478/ https://www.ncbi.nlm.nih.gov/pubmed/28279639 http://dx.doi.org/10.1016/j.ebiom.2017.02.027 |
work_keys_str_mv | AT huangchungfeng corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT huangchingi corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT yehminglun corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT wangshuchi corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chenkuanyu corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT koyumin corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT linchingchih corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT tsaiyishan corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT tsaipeichien corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT linzuyau corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chenshinncherng corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT daichiayen corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT huangjeefu corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT chuangwanlong corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 AT yuminglung corrigendumtogeneticsvariantsandserumlevelsofmhcclassichainrelatedainpredictinghepatocellularcarcinomadevelopmentinchronichepatitiscpatientspostantiviraltreatmentebiomedicine1520178189 |